Innophore

Explore the platform for protein and drug discovery. Innophore is a cutting-edge drug and enzyme discovery platform that uses an artificial intelligence guided point-cloud technology to identify and optimize protein candidates for various use cases. We have leading global customers in the biotech and pharmaceutical industry, including Henkel, Continental, Merck and leading companies in the field of flavours and fragrances. Our AI-driven platform, fueled by massive computing power, not only analyzes a proteins 3D structure, but includes extended surface properties (HALOS) and volumetric cavities (catalophores), to predict its characteristics and reactivity. This puts our customers at the forefront of tackling...

Structural bioinformatics,enzyme discovery,automated substrate docking,automated homology modelling,drug design,biopharmaceuticals,therapeutics,molecular dynamics simulations software,3d point-cloud technology,drug discovery platform,drug development tech,ai platform,biologics and materials design,biocatalysis,and in-silico protein modification

Innophore operates in the Biotechnology research industry.

Innophore's revenue is 11m - 100m

Innophore has 11 - 50 employees.